Seisenbacher Jonathan, Kavallar Anna M, Mayerhofer Christoph, Aldrian Denise, Hackl Lukas, Müller Thomas, Vogel Georg F
Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
J Pediatr Gastroenterol Nutr. 2025 Aug;81(2):192-203. doi: 10.1002/jpn3.70093. Epub 2025 May 30.
Biliary strictures (BS) remain frequent after pediatric liver transplantation (pLT) and best management practices are still lacking. This study systematically assesses efficacy of stricture treatment by percutaneous transhepatic cholangiography and drainage (PTCD).
Online databases were searched for studies on PTCD treatment of BS after pLT from the year 2000 to 2024. Efficacy and safety profile of PTCD were analyzed. Influence of various risk factors on outcome parameters was compared by meta-regression.
Twenty-seven observational studies with 802 patients undergoing PTCD for BS met the inclusion criteria. Incidence of BS was 13.1% (95% confidence interval [CI]: 10.3-16.1) in 6543 patients reported who underwent pLT between 1989 and 2020. Overall efficacy of PTCD to achieve stricture resolution was 78.3% (95% CI: 66.5-80.4). Drainage duration longer or shorter than 109.1 days did not impact on achievement of resolution with efficacies of 76.5% (95% CI: 65.4-86.2) in short versus 75.1% (95% CI: 61.9-86.5, p = 0.87) in long drainage. Overall recurrence rate after stricture resolution was 16.0% (95% CI: 7.5-26.3). Drainage duration longer or shorter than 109.1 days did not affect recurrence rate which was 17.4% (95% CI: 3.3-37.3) in short versus 20.9% (95% CI: 14.0-28.5, p = 0.68) in long drainage duration. Overall rate of procedure-related complications was 9.9% (95% CI: 2.6-20.0, p = 0.99) and was not influenced by drainage duration.
PTCD is efficient to treat BS after pLT. Drainage time does not impact efficacy, recurrence rate, and complication rate. Randomized trials are necessary to determine the best treatment protocol concerning drainage duration and intervals between interventions.
小儿肝移植(pLT)后胆管狭窄(BS)仍然常见,且仍缺乏最佳管理方法。本研究系统评估经皮经肝胆管造影和引流(PTCD)治疗胆管狭窄的疗效。
检索在线数据库中2000年至2024年关于PTCD治疗pLT后BS的研究。分析PTCD的疗效和安全性。通过Meta回归比较各种风险因素对结局参数的影响。
27项观察性研究共802例因BS接受PTCD的患者符合纳入标准。1989年至2020年间接受pLT的6543例患者中,BS的发生率为13.1%(95%置信区间[CI]:10.3 - 16.1)。PTCD实现狭窄缓解的总体有效率为78.3%(95%CI:66.5 - 80.4)。引流时间长于或短于109.1天对缓解成功率无影响,短引流组有效率为76.5%(95%CI:65.4 - 86.2),长引流组为75.1%(95%CI:61.9 - 86.5,p = 0.87)。狭窄缓解后的总体复发率为16.0%(95%CI:7.5 - 26.3)。引流时间长于或短于109.1天对复发率无影响,短引流组复发率为17.4%(95%CI:3.3 - 37.3),长引流组为20.9%(95%CI:14.0 - 28.5,p = 0.68)。总体手术相关并发症发生率为9.9%(95%CI:2.6 - 20.0,p = 0.99),且不受引流时间影响。
PTCD治疗pLT后的BS有效。引流时间不影响疗效、复发率和并发症发生率。需要进行随机试验以确定关于引流持续时间和干预间隔的最佳治疗方案。